Loading...
Loading...
SIBN| Name | Value |
|---|---|
| Revenues | 32.0M |
| Cost of Revenue | 5.1M |
| Gross Profit | 26.9M |
| Operating Expense | 38.2M |
| Operating I/L | -11.3M |
| Other Income/Expense | 0.1M |
| Interest Income | 0.7M |
| Pretax | -11.2M |
| Income Tax Expense | -0.1M |
| Net Income/Loss | -11.1M |
SI-BONE, Inc. is a medical device company specializing in implantable devices for musculoskeletal disorders of the sacropelvic anatomy. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address sacroiliac joint dysfunction, degeneration, adult deformity, and pelvic ring traumatic fractures. The company also offers iFuse-3D, a titanium implant featuring a proprietary 3D-printed porous surface and fenestrated design, and iFuse-TORQ, a set of 3D-printed threaded implants for treating pelvis fractures and sacroiliac joint fusion. SI-BONE generates revenue primarily through direct sales and distributor partnerships.
